Analyzing the clinical data for Aduhelm, Biogen's controversial Alzheimer's drug

[@TheYvian]

Interesting and much appreciated. Following this with a curious mind!

[@blondscientist]

Thanks for this! Super helpful!

[@mauriziopilato6210]

Would you be so kind to valuate Cassava Sciences. Small Biotech in the Alzheimer's Space.
Thx.

[@davidlarose8808]

Great video! Binge watching all your channel right now. Any resources to learn more about the pharma industry for someone targeting a market access job in big pharma?

[@baybridgebio2576]

Thanks! I don’t have too much market access experience so not sure what resources would be most helpful.

[@alexabouezzi1000]

Well, I hate to break it to you but 2 days after the video came out biogen put out the 3rd phase 3 study for aduhelm

[@omkarbhatavdekar3757]

Great content!